Advances in Inner Ear Drug Delivery in Mice
Main Article Content
Keywords
inner ear drug delivery, mouse model, blood-labyrinth barrier, nanocarriers, sensorineural hearing loss
Abstract
Drug delivery to the inner ear is a key technology for treating sensorineural hearing loss. Due to the presence of physiological barriers such as the blood-labyrinth barrier and the round window membrane, it is difficult for drugs to effectively reach target tissues in the inner ear. Mouse models, with their well-defined genetic backgrounds and short breeding cycles, have become the primary tools for research on inner ear drug delivery. This article reviews the main obstacles and delivery strategies of drug delivery in the inner ear of mice, focusing on the research progress of intratympanic injection, direct cochlear injection, nanocarriers, hydrogels and gene delivery vehicles. The advantages and disadvantages of each method and the corresponding precise delivery strategies for different deafness types are analyzed, and future directions in this field are discussed.
References
- [1]Wu, H., Ding, Y., & Chen, X. (2026). Recent advances in novel drug carriers and advanced administration routes for inner ear drug delivery: Challenges and future perspectives. International Journal of Pharmaceutics, 698, Article 126949. https://doi.org/10.1016/j.ijpharm.2026.126949
- [2]Jimoh, O. O., Ajuwon, T., Okonkwo, S. S., Awoyemi, R. F., Olaosebikan, I., Olahanmi, O. A., Mbonu, C., Junaid, I. O., Odezuligbo, I., Olotu, K., & Ifijen, I. H. (2026). PLGA nanoparticles in otoprotection and inner ear regeneration: A new frontier in nanomedicine for hearing disorders. RSC Advances, 16(1), 76–106. https://doi.org/10.1039/D5RA06007A
- [3]Shu, Y., Cai, S., Fan, X., Zhang, L., & Wang, J. (2025). Targeted inner ear drug delivery empowering gene therapy for congenital hearing loss: Strategies, challenges and prospects (in Chinese). Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 31(6), 1–10. https://doi.org/10.11798/j.issn.1007-1520.202525475
- [4]Kim, D.-K. (2025). Recent advances in functionalized nanoparticles for targeted and controlled inner ear therapy via localized cochlear delivery. Journal of Audiology & Otology, 29(3), 159–165. https://doi.org/10.7874/jao.2025.00311
- [5]Cai, Q., Chai, R., Chen, G., Chen, Y., Feng, N., Leng, Y., Liu, Y., Lu, L., Ren, D., Wang, Z., Wang, G., Wang, W., Wu, X., Xia, M., Xiong, H., Xu, L., Zhang, H., Zhang, J., Zhang, T., … Sun, Y. (2024). Clinical practice guidelines for intratympanic drug delivery (in Chinese). Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 30(1), 1–11. https://doi.org/10.11798/j.issn.1007-1520.202423362
- [6]Wen, D., Zhang, L., Deng, P., Li, H., Feng, X., Wen, L., & Chen, G. (2026). Tracking the spatiotemporal journey of chitosan nanoparticles across ear physiological barriers: Mechanisms and pathways. Drug Metabolism and Disposition, 54(3), Article 100233. https://doi.org/10.1016/j.dmd.2026.100233
- [7]Zou, J. (2025). The neglected oval window pathway from tympanic cavity to vestibule is highly efficient (in Chinese). Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 60(2), 113–117. https://doi.org/10.3760/cma.j.cn115330-20240225-00104
- [8]Zhang, H., Mao, X., & Chu, C. (2025). AAV-mediated gene therapy for the inner ear: Progress, challenges, and future directions. ENT Discovery, 1(2), 39–48. https://doi.org/10.15302/ENTD.2025.120006
- [9]Zhang, P., & Diao, M. (2026). Nanocarriers for local inner ear drug administration (in Chinese). Chinese Journal of Otology, 24(9), 917–921. https://doi.org/10.3969/j.issn.1672-2922.2026.09.015
- [10]Xu, K., Li, W., Jiang, Q., Yu, D., Chen, Y., & Wang, X. (2025). Nanomodulation of blood-labyrinth barrier enhances neuroprotection and antioxidant intervention for noise-induced hearing loss. Journal of Controlled Release, 385, Article 114006. https://doi.org/10.1016/j.jconrel.2025.114006
- [11]Zhai, T., Ai, P., Tang, Z., He, C., Chen, X., Yang, S., & Wu, N. (2023). Intratympanic injection of hydrogel nanodrug for the prevention and treatment of sensorineural hearing loss. Journal of Otology, 18(4), 235–239. https://doi.org/10.1016/j.joto.2023.09.005
- [12]Chen, Y., Gu, J., Liu, J., Tong, L., Shi, F., Wang, X., Wang, X., Yu, D., & Wu, H. (2019). Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity. International Journal of Nanomedicine, 14, 4211–4227. https://doi.org/10.2147/IJN.S195336
- [13]Han, S. (2023). Specific targeting and biodistribution of adeno-associated viral vectors for inner ear delivery (in Chinese) [Thesis, Jilin University].
